Pierre Beaurang, Chief Business Officer at Nurix Therapeutics, Inc. (NRIX), sold 14,800 shares at $36.48 ($548K) on 2021-03-08, disclosed to the SEC on 2021-03-09.
Open-market sale of $548k NRIX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.48 | 2,810 | $103K | 18.7% |
| 2 | $36.48 | 2,810 | $103K | 18.7% |
| 3 | $37.31 | 4,490 | $168K | 30.6% |
| 4 | $37.31 | 4,490 | $168K | 30.6% |
| 5 | $38.34 | 200 | $8K | 1.4% |
| Total | $37.01 avg | 14,800 |
| $548K |
| 100% |
| Filing → |
| NRIX | SELL | 2021-06-11 | $220K | — | Filing → |
| NRIX | SELL | 2021-05-11 | $378K | — | Filing → |
| NRIX | SELL | 2021-04-13 | $394K | — | Filing → |